BSB-1001 in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant for AML, ALL or MDS

NCT06704152 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

AML, Adult Recurrent
ALL, Recurrent, Adult
MDS

Interventions

DRUG: SOC + BSB-1001 Dose Escalation Cohort
DRUG: SOC+BSB-1001 Expansion Dose

Sponsor

BlueSphere Bio, Inc